Camtek details planned sale of 3,296 ordinary shares

Camtek Ltd filed a notice for the potential sale of 3,296 Ordinary Shares through Oppenheimer & Co. Inc. on Nasdaq around 08/11/2026, with an aggregate market value of 521097.60 and 45828133 shares outstanding.

Rhea-AI Filing Summary

Camtek Ltd filed a notice for the potential sale of 3,296 Ordinary Shares through Oppenheimer & Co. Inc. on Nasdaq around 08/11/2026, with an aggregate market value of 521097.60 and 45828133 shares outstanding. The shares were acquired via RSU vestings of 9,738 shares on 01/16/2024, 5,564 on 02/15/2024, and 2,206 on 04/01/2025, each for no cash consideration.

Key Figures

Shares to be sold: 3296 shares Aggregate market value of shares to be sold: 521097.60 Shares outstanding: 45828133 shares +4 more

7 metrics

Shares to be sold 3296 shares Ordinary Shares proposed for sale under Rule 144

Aggregate market value of shares to be sold 521097.60 Value of 3,296 Ordinary Shares proposed for sale

Shares outstanding 45828133 shares Ordinary Shares outstanding at time of notice

RSU vesting on 01/16/2024 9738 shares Ordinary Shares issued upon vesting of RSUs, no consideration

RSU vesting on 02/15/2024 5564 shares Ordinary Shares issued upon vesting of RSUs, no consideration

RSU vesting on 04/01/2025 2206 shares Ordinary Shares issued upon vesting of RSUs, no consideration

Proposed sale date 08/11/2026 Date listed for potential Rule 144 sales on Nasdaq

Key Terms

Rule 144, Ordinary Shares, vesting of RSUs, aggregate market value

4 terms

Rule 144 regulatory

"planned Rule 144 sale of 3,296 ordinary shares on Nasdaq"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Ordinary Shares financial

"Camtek Ltd has 45828133 Ordinary Shares outstanding"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

vesting of RSUs financial

"Shares issued upon vesting of RSUs on 01/16/2024"

aggregate market value financial

"aggregate market value of 521097.60 for 3,296 shares"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is Camtek Ltd (CAMT) registering in this Form 144?

Camtek Ltd is registering a proposed sale of 3,296 Ordinary Shares through Oppenheimer & Co. Inc. The shares are planned to be sold on Nasdaq, with an aggregate market value of 521097.60 as indicated in the notice.

When are the CAMT shares covered by this Form 144 expected to be sold?

The notice lists a proposed sale date of 08/11/2026 for the 3,296 Ordinary Shares. This is an anticipated date for potential sales under Rule 144 rather than a firm execution commitment.

How many Camtek Ltd (CAMT) shares are outstanding according to the Form 144?

The filing states that Camtek Ltd has 45828133 Ordinary Shares outstanding. This figure serves as context for the relative size of the 3,296-share proposed sale under Rule 144.

How did the reporting holder acquire the CAMT shares being sold under Form 144?

The shares to be sold were acquired through RSU vestings: 9,738 shares on 01/16/2024, 5,564 on 02/15/2024, and 2,206 on 04/01/2025. Each RSU vesting involved no cash consideration to the issuer.

On which market will the Camtek Ltd (CAMT) Form 144 shares trade?

The proposed sale of 3,296 Ordinary Shares is listed to occur on the Nasdaq market. Oppenheimer & Co. Inc. is named as the broker handling these potential Rule 144 transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 07:44 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972379
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMTEK LTD
SEC File Number	000-30664
Address of Issuer	INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK ISRAEL 23150
Phone	972-4-604-8100
Name of Person for Whose Account the Securities are To Be Sold	Eisenberg Moshe
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	3296	521097.60	45828133	08/11/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	01/16/2024	Shares issued upon vesting of RSUs	CAMTEK LTD			9738	01/16/2024	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	02/15/2024	Shares issued upon vesting of RSUs	CAMTEK LTD			5564	02/15/2024	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	04/01/2025	Shares issued upon vesting of RSUs	CAMTEK LTD			2206	04/01/2025	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Moshe Eisenberg By: /s/ Meirav Shemesh Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)